Intellectual Property News & Topics - Secerna LLP

XTANDI

A to Z: Drugs in Highlight: X is for XTANDI®

News A to Z Feature 15/05/2025

Our A to Z series highlights XTANDI® (from Pfizer and Astellas Pharma) is used to treat men with prostate cancer. Learn more about XTANDI®'s mechanism of action, market impact, and patent protection.

Read more

Networking Breakfast

Events, News, Team news 27/04/2025

Protecting Your Innovation: An Intellectual Property (IP) Breakfast for Businesses and Innovators

A To Z Drugs In Highlight U Is For UPTRAVI

News, A to Z Feature 24/04/2025

A to Z: Drugs in Highlight: U is for UPTRAVI®

A To Z Drugs In Highlight T Is For TECFIDERA®

News, A to Z Feature 17/04/2025

A to Z: Drugs in Highlight: T is for TECFIDERA®

European, News 16/04/2025

Updated European Patent Office Examination Guidelines for AI Inventions

Use It Or Lose It A Reminder To The Holders Of Comparable Registrations Main

European, News 15/04/2025

Use it or Lose it: A reminder to the holders of Comparable Registrations

STRIBILD

News, A to Z Feature 10/04/2025

A to Z: Drugs in Highlight: S is for STRIBILD®

Seas The Day Start

Events, News 08/04/2025

Seas The Day: Pacific Row Begins - Follow Their Epic Journey

JBOAKES - Secerna

Events, News, Team news 07/04/2025

Jason Boakes will be in San Diego (17th - 22nd May)

REXULTI

News, A to Z Feature 03/04/2025

A to Z: Drugs in Highlight: R is for REXULTI®

1 2 3 4 5 6 7